- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x FMT: FORMIC ACID(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 9 residues within 4Å:- Chain A: F.6, K.7, R.210, L.214, V.216, M.225, A.226, L.227, E.466
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.7, A:R.210, A:A.226
EDO.4: 5 residues within 4Å:- Chain A: E.395, W.433, N.436, M.437, N.442
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.395, A:W.433
EDO.5: 10 residues within 4Å:- Chain A: H.194, A.195, V.216, Y.219, E.220, L.221, N.223, P.224, M.225, L.227
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:A.195, A:E.220, A:N.223, A:N.223
EDO.22: 5 residues within 4Å:- Chain A: L.363, F.440, S.446, A.447, P.448
No protein-ligand interaction detected (PLIP)- 1 x 5GF: 5-fluoro-beta-D-glucopyranose(Post Translational Modification)
5GF.19: 17 residues within 4Å:- Chain A: W.314, D.342, I.343, I.379, D.381, W.416, W.453, D.455, M.456, R.515, W.528, G.530, D.531, D.560, F.564, R.587, H.589
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:D.342, A:W.416, A:R.515, A:D.531, A:D.531, A:H.589
- Water bridges: A:D.531, A:D.531
- 2 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
P6G.20: 8 residues within 4Å:- Chain A: P.79, R.80, Y.81, R.82, P.84, Y.476, G.477, W.479
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.479
- Water bridges: A:Y.81
P6G.23: 10 residues within 4Å:- Chain A: T.298, Y.629, H.632, K.633, Y.767, Q.768, H.771, F.773, D.791, K.793
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.633, A:D.791
- 2 x OXM: OXAMIC ACID(Non-covalent)
OXM.21: 4 residues within 4Å:- Chain A: N.315, R.317, E.344, R.358
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.358
OXM.24: 6 residues within 4Å:- Chain A: K.375, P.448, N.449, Y.451, E.508, H.763
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.375
- Salt bridges: A:K.375
- 2 x CA: CALCIUM ION(Non-covalent)
CA.26: 8 residues within 4Å:- Chain A: R.842
- Chain B: Q.16, D.19, Y.21, C.22, D.23, D.29, E.30
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:Q.16, B:D.19, B:Y.21, B:D.23, B:D.29, B:E.30
CA.27: 8 residues within 4Å:- Chain B: R.57, V.58, N.59, D.60, V.62, D.64, D.70, E.71
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:R.57, B:D.60, B:V.62, B:D.64, B:D.70, B:E.71
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Caputo, A.T. et al., Structures of mammalian ER alpha-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals. Proc.Natl.Acad.Sci.USA (2016)
- Release Date
- 2016-07-27
- Peptides
- Neutral alpha-glucosidase AB: A
Glucosidase 2 subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x FMT: FORMIC ACID(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x 5GF: 5-fluoro-beta-D-glucopyranose(Post Translational Modification)
- 2 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
- 2 x OXM: OXAMIC ACID(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Caputo, A.T. et al., Structures of mammalian ER alpha-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals. Proc.Natl.Acad.Sci.USA (2016)
- Release Date
- 2016-07-27
- Peptides
- Neutral alpha-glucosidase AB: A
Glucosidase 2 subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D